Possible relevant behaviors include infant temperament and developmental milestones at 9 months
TUESDAY, April 22, 2025 (HealthDay News) — Maternal report of infant temperament and developmental milestones at 9 months of age may be associated with early indicators of autism likelihood at 12 months, according to a study recently published online in Pediatric Research.
Erin M. Andres, Ph.D., from the University of Missouri-Columbia, and colleagues used data from a prospective general population birth cohort with maternal-reported measures at 9 and 12 months of age (332 infants) to identify behaviors relevant to early autism screening.
The researchers found that maternal-reported infant developmental milestones and behavioral indicators of difficult temperament, poor adaptability, and sleep problems at 9 months and maternal self-reported subclinical autism characteristics were correlated with maternal-reported, autism-related behaviors at 12 months. There were significant unique associations of infant temperament and developmental milestones with First Year Inventory-Lite v3.1b scores, when controlling for significant effects of maternal Broad Autism Phenotype Questionnaire scores and education.
“Maternal report of infant temperament and developmental milestones at 9 months were associated with maternal-report early indicators of autism likelihood at 12 months in a general birth cohort,” the authors write. “Follow-up of this cohort is needed to determine associations with formal diagnostic outcomes.”
Abstract/Full Text (subscription or payment may be required)
Altered Markers of Ovarian Development Seen With Fetal Acetaminophen Exposure
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis
U.S. Adults May Not Understand Their Risk for Vascular Disease
People With Autism Have Shorter Life Expectancy
Autism Spectrum Disorder Diagnoses Increased for Females Since 2020
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing